Related references
Note: Only part of the references are listed.P2X7 Variants in Oncogenesis
Anna Pegoraro et al.
CELLS (2021)
P2X7 in Cancer: From Molecular Mechanisms to Therapeutics
Romain Lara et al.
FRONTIERS IN PHARMACOLOGY (2020)
P2X7 receptor antagonism inhibits tumour growth in human high-grade gliomas
Liyen Katrina Kan et al.
PURINERGIC SIGNALLING (2020)
P2X7 Receptor Promotes Mouse Mammary Cancer Cell Invasiveness and Tumour Progression, and Is a Target for Anticancer Treatment
Lucie Brisson et al.
CANCERS (2020)
Anti-inflammatory Effects and Mechanisms of Rhein, an Anthraquinone Compound, and Its Applications in Treating Arthritis: A Review
Hongjuan Wang et al.
NATURAL PRODUCTS AND BIOPROSPECTING (2020)
P2RX7B is a new theranostic marker for lung adenocarcinoma patients
Jonathan Benzaquen et al.
THERANOSTICS (2020)
Highly-expressed P2X7 receptor promotes growth and metastasis of human HOS/MNNG osteosarcoma cells via PI3K/Akt/GSK3β/β-catenin and mTOR/HIF1α/VEGF signaling
Yingchi Zhang et al.
INTERNATIONAL JOURNAL OF CANCER (2019)
P2X7 Receptor Expression in Patients With Serositis Related to Systemic Lupus Erythematosus
Federica Furini et al.
FRONTIERS IN PHARMACOLOGY (2019)
Antidepressant-like Effects Induced by Chronic Blockade of the Purinergic 2X7 Receptor through Inhibition of Non-like Receptor Protein 1 Inflammasome in Chronic Unpredictable Mild Stress Model of Depression in Rats
Feyza Aricioglu et al.
CLINICAL PSYCHOPHARMACOLOGY AND NEUROSCIENCE (2019)
Mapping the Site of Action of Human P2X7 Receptor Antagonists AZ11645373, Brilliant Blue G, KN-62, Calmidazolium, and ZINC58368839 to the Intersubunit Allosteric Pocket
Anfal Bin Dayel et al.
MOLECULAR PHARMACOLOGY (2019)
P2X7 Interactions and Signaling - Making Head or Tail of It
Robin Kopp et al.
FRONTIERS IN MOLECULAR NEUROSCIENCE (2019)
The P2X7 receptor modulates immune cells infiltration, ectonucleotidases expression and extracellular ATP levels in the tumor microenvironment
Elena De Marchi et al.
ONCOGENE (2019)
A Dipolar Cycloaddition Reaction To Access 6-Methyl-4,5,6,7-tetrahydro-1H[1,2,3]triazolo[4,5-c]pyridines Enables the Discovery Synthesis and Preclinical Profiling of a P2X7 Antagonist Clinical Candidate
Christa C. Chrovian et al.
JOURNAL OF MEDICINAL CHEMISTRY (2018)
The potential of P2X7 receptors as a therapeutic target, including inflammation and tumour progression
Geoffrey Burnstock et al.
PURINERGIC SIGNALLING (2018)
The P2X7 receptor: A main player in inflammation
Elena Adinolfi et al.
BIOCHEMICAL PHARMACOLOGY (2018)
Mapping the Allosteric Action of Antagonists A740003 and A438079 Reveals a Role for the Left Flipper in Ligand Sensitivity at P2X7 Receptors
Rebecca C. Allsopp et al.
MOLECULAR PHARMACOLOGY (2018)
Activating P2X7 Receptors Increases Proliferation of Human Pancreatic Cancer Cells via ERK1/2 and JNK
Ji Hun Choi et al.
PANCREAS (2018)
Involvement of P2X7 Receptor in Proliferation and Migration of Human Glioma Cells
Zhenhua Ji et al.
BIOMED RESEARCH INTERNATIONAL (2018)
Recent Advances in CNS P2X7 Physiology and Pharmacology: Focus on Neuropsychiatric Disorders
Anindya Bhattacharya
FRONTIERS IN PHARMACOLOGY (2018)
The P2X7 Receptor in Inflammatory Diseases: Angel or Demon?
Luiz E. B. Savio et al.
FRONTIERS IN PHARMACOLOGY (2018)
ATP/P2X7 receptor signaling as a potential anti-inflammatory target of natural polyphenols
Erika Nuka et al.
PLOS ONE (2018)
Characterization of 11C-GSK1482160 for Targeting the P2X7 Receptor as a Biomarker for Neuroinflammation
Paul R. Territo et al.
JOURNAL OF NUCLEAR MEDICINE (2017)
The P2X7 Receptor in Infection and Inflammation
Francesco Di Virgilio et al.
IMMUNITY (2017)
P2X7 receptor antagonism prevents IL-1β release from salivary epithelial cells and reduces inflammation in a mouse model of autoimmune exocrinopathy
Mahmoud G. Khalafalla et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2017)
4-Methyl-6,7-dihydro-4H-triazolo[4,5-c]pyridine-Based P2X7 Receptor Antagonists: Optimization of Pharmacokinetic Properties Leading to the Identification of a Clinical Candidate
Michael A. Letavic et al.
JOURNAL OF MEDICINAL CHEMISTRY (2017)
Site-Specific Regulation of P2X7 Receptor Function in Microglia Gates Morphine Analgesic Tolerance
Heather Leduc-Pessah et al.
JOURNAL OF NEUROSCIENCE (2017)
Lack of chemopreventive effects of P2X7R inhibitors against pancreatic cancer
Altaf Mohammed et al.
ONCOTARGET (2017)
Unique residues in the ATP gated human P2X7 receptor define a novel allosteric binding pocket for the selective antagonist AZ10606120
Rebecca C. Allsopp et al.
SCIENTIFIC REPORTS (2017)
The P2X7 receptor antagonist Brilliant Blue G reduces serum human interferon- in a humanized mouse model of graft-versus-host disease
N. J. Geraghty et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2017)
Targeting of the P2X7 receptor in pancreatic cancer and stellate cells
Andrea Giannuzzo et al.
INTERNATIONAL JOURNAL OF CANCER (2016)
P2X7 targeting inhibits growth of human mesothelioma
Francesca Amoroso et al.
ONCOTARGET (2016)
Human iNKT Cells Promote Protective Inflammation by Inducing Oscillating Purinergic Signaling in Monocyte-Derived DCs
Xuequn Xu et al.
CELL REPORTS (2016)
Structural basis for subtype-specific inhibition of the P2X7 receptor
Akira Karasawa et al.
ELIFE (2016)
Understanding the roles of the P2X7 receptor in solid tumour progression and therapeutic perspectives
Sebastien Roger et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES (2015)
P2X7 receptor predicts postoperative cancer-specific survival of patients with clear-cell renal cell carcinoma
Zheng Liu et al.
CANCER SCIENCE (2015)
The P2X7 receptor is a key modulator of the PI3K/GSK3β/VEGF signaling network: evidence in experimental neuroblastoma
F. Amoroso et al.
ONCOGENE (2015)
Rhein antagonizes P2X7 receptor in rat peritoneal macrophages
Fen Hu et al.
SCIENTIFIC REPORTS (2015)
PI3K/Akt signaling pathway triggers P2X7 receptor expression as a pro-survival factor of neuroblastoma cells under limiting growth conditions
Rosa Gomez-Villafuertes et al.
SCIENTIFIC REPORTS (2015)
The NLRP3 Inflammasome Is a Pathogen Sensor for Invasive Entamoeba histolytica via Activation of α5β1 Integrin at the Macrophage-Amebae Intercellular Junction
Leanne Mortimer et al.
PLOS PATHOGENS (2015)
Synthesis and initial preclinical evaluation of the P2X7 receptor antagonist [11C]A-740003 as a novel tracer of neuroinflammation
Bieneke Janssen et al.
JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS (2014)
The P2X7 receptor antagonist Brilliant Blue G attenuates contralateral rotations in a rat model of Parkinsonism through a combined control of synaptotoxicity, neurotoxicity and gliosis
Marta R. S. Carmo et al.
NEUROPHARMACOLOGY (2014)
Natural compounds with P2X7 receptor-modulating properties
Wolfgang Fischer et al.
PURINERGIC SIGNALLING (2014)
Pharmacology of a Novel Central Nervous System-Penetrant P2X7 Antagonist JNJ-42253432
Brian Lord et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2014)
Dual Gating Mechanism and Function of P2X7 Receptor Channels
Anmar Khadra et al.
BIOPHYSICAL JOURNAL (2013)
Pharmacokinetic and pharmacodynamic profiling of a P2X7 receptor allosteric modulator GSK1482160 in healthy human subjects
Zahid Ali et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2013)
Pharmacological characterization of a novel centrally permeable P2X7 receptor antagonist: JNJ-47965567
Anindya Bhattacharya et al.
BRITISH JOURNAL OF PHARMACOLOGY (2013)
Anthraquinone emodin inhibits human cancer cell invasiveness by antagonizing P2X7 receptors
Bilel Jelassi et al.
CARCINOGENESIS (2013)
Effect of the Purinergic Inhibitor Oxidized ATP in a Model of Islet Allograft Rejection
Andrea Vergani et al.
DIABETES (2013)
The Phosphoinositide-3-Kinase-Akt-mTOR Pathway as a Therapeutic Target in Breast Cancer
Josh y Lauring et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2013)
Characterization of P2X7R and Its Function in the Macrophages of ayu, Plecoglossus altivelis
Yu-Qing He et al.
PLOS ONE (2013)
Primitive ATP-activated P2X receptors: discovery, function and pharmacology
Samuel J. Fountain
FRONTIERS IN CELLULAR NEUROSCIENCE (2013)
P2X7-mediated calcium influx triggers a sustained, PI3K-dependent increase in metabolic acid production by osteoblast-like cells
Matthew W. Grol et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2012)
Efficacy and Safety of CE-224,535, an Antagonist of P2X7 Receptor, in Treatment of Patients with Rheumatoid Arthritis Inadequately Controlled by Methotrexate
Thomas C. Stock et al.
JOURNAL OF RHEUMATOLOGY (2012)
VEGF is essential for the growth and migration of human hepatocellular carcinoma cells
Lei Zhang et al.
MOLECULAR BIOLOGY REPORTS (2012)
The P2X7 receptor is a key modulator of aerobic glycolysis
F. Amoroso et al.
CELL DEATH & DISEASE (2012)
Optimization of the physicochemical and pharmacokinetic attributes in a 6-azauracil series of P2X7 receptor antagonists leading to the discovery of the clinical candidate CE-224,535
Allen J. Duplantier et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2011)
P2X7 receptor antagonism in the treatment of cancers
Sebastien Roger et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2011)
P2X7 Receptors Trigger ATP Exocytosis and Modify Secretory Vesicle Dynamics in Neuroblastoma Cells
Yolanda Gutierrez-Martin et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Block of Purinergic P2X(7)R Inhibits Tumor Growth in a C6 Glioma Brain Tumor Animal Model
Jae K. Ryu et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2011)
P2X7 receptor activation enhances SK3 channels- and cystein cathepsin-dependent cancer cells invasiveness
B. Jelassi et al.
ONCOGENE (2011)
PI3K/AKT/mTOR pathway in angiogenesis
Jayashree Karar et al.
FRONTIERS IN MOLECULAR NEUROSCIENCE (2011)
The birth and postnatal development of purinergic signalling
G. Burnstock et al.
ACTA PHYSIOLOGICA (2010)
gamma-Irradiation induces P2X(7) receptor-dependent ATP release from B16 melanoma cells
Yasuhiro Ohshima et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2010)
Discovery and structure-activity relationships of a series of pyroglutamic acid amide antagonists of the P2X(7) receptor
Muna H. Abdi et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2010)
Inhibition of ATP-induced macrophage death by emodin via antagonizing P2X7 receptor
Lijun Liu et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2010)
Evolutionary origins of the purinergic signalling system
G. Burnstock et al.
ACTA PHYSIOLOGICA (2009)
Activation of P2X7 receptors causes isoform-specific translocation of protein kinase C in osteoclasts
Souzan Armstrong et al.
JOURNAL OF CELL SCIENCE (2009)
The P2X7 Receptor Drives Microglial Activation and Proliferation: A Trophic Role for P2X7R Pore
Mastura Monif et al.
JOURNAL OF NEUROSCIENCE (2009)
Targeting the phosphoinositide 3-kinase pathway in cancer
Pixu Liu et al.
NATURE REVIEWS DRUG DISCOVERY (2009)
Systemic administration of an antagonist of the ATP-sensitive receptor P2X7 improves recovery after spinal cord injury
Weiguo Peng et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
P2X7 receptor expression is decreased in epithelial cancer cells of ectodermal, uro-genital sinus, and distal paramesonephric duct origin
Xin Li et al.
PURINERGIC SIGNALLING (2009)
Trophic functions of nucleotides in the central nervous system
Joseph T. Neary et al.
TRENDS IN NEUROSCIENCES (2009)
An in vivo evaluation of Brilliant Blue G in animals and humans
M. Remy et al.
BRITISH JOURNAL OF OPHTHALMOLOGY (2008)
Rho GTPases in cancer cell biology
Francisco M. Vega et al.
FEBS LETTERS (2008)
Unresolved issues and controversies in purinergic signalling
Geoffrey Burnstock
JOURNAL OF PHYSIOLOGY-LONDON (2008)
Increased Level of Extracellular ATP at Tumor Sites: In Vivo Imaging with Plasma Membrane Luciferase
Patrizia Pellegatti et al.
PLOS ONE (2008)
P2x7-related modulation of pathological nociception in rats
S. McGaraughty et al.
NEUROSCIENCE (2007)
A-740003 [N-(1-{[(cyanoimino)(5-quinolinylamino)methyl]amino}-2,2-dimethylpropyl)-2-(3,4-dimethoxyphenyl)acetamide], a novel and selective P2X7 receptor antagonist, dose-dependently reduces neuropathic pain in the rat
Prisca Honore et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2006)
Structure-activity relationship studies on a series of novel, substituted 1-benzyl-5-phenyltetrazole P2X7 antagonists
Derek W. Nelson et al.
JOURNAL OF MEDICINAL CHEMISTRY (2006)
Ras, PI(3)K and mTOR signalling controls tumour cell growth
Reuben J. Shaw et al.
NATURE (2006)
Basal activation of the P2X7 ATP receptor elevates mitochondrial calcium and potential, increases cellular ATP levels, and promotes serum-independent growth
E Adinolfi et al.
MOLECULAR BIOLOGY OF THE CELL (2005)
Early prostate cancer detected using expression of non-functional cytolytic P2X7 receptors
M Slater et al.
HISTOPATHOLOGY (2004)
Differentiation between cancerous and normal hyperplastic lobules in breast lesions
M Slater et al.
BREAST CANCER RESEARCH AND TREATMENT (2004)
Agonists and antagonists acting at P2X(7) receptor
PG Baraldi et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2004)
Oxidized ATP (oATP) attenuates proinflammatory signaling via P2 receptor-independent mechanisms
RD Beigi et al.
BRITISH JOURNAL OF PHARMACOLOGY (2003)
ATP as a signaling molecule: The exocrine focus
I Novak
NEWS IN PHYSIOLOGICAL SCIENCES (2003)
Mechanisms of P2X7 receptor-mediated ERK1/2 phosphorylation in human astrocytoma cells
FP Gendron et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2003)
Characteristics of ATP-induced current through P2X7 receptor in NG108-15 cells:: Unique antagonist sensitivity and lack of pore formation
T Watano et al.
JAPANESE JOURNAL OF PHARMACOLOGY (2002)
Proteomic and functional evidence for a P2X7 receptor signalling complex
M Kim et al.
EMBO JOURNAL (2001)
Ten years of protein kinase B signalling: a hard Akt to follow
DP Brazil et al.
TRENDS IN BIOCHEMICAL SCIENCES (2001)
Brilliant Blue G selectively blocks ATP-gated rat P2X7 receptors
LH Jiang et al.
MOLECULAR PHARMACOLOGY (2000)
Share Paper
